Literature DB >> 22548492

First-degree relatives of patients with early-onset gastric carcinoma show even at young ages a high prevalence of advanced OLGA/OLGIM stages and dysplasia.

R Marcos-Pinto1, F Carneiro, M Dinis-Ribeiro, X Wen, C Lopes, C Figueiredo, J C Machado, R M Ferreira, C A Reis, J Ferreira, I Pedroto, J Areias.   

Abstract

BACKGROUND: First-degree relatives (FDRs) of early-onset gastric carcinoma (EOGC) patients are at increased risk of cancer development. OLGA/OLGIM (Operative Link on Gastritis/Intestinal Metaplasia Assessment) classifications have been proposed for the identification of individuals at high risk of gastric cancer development. AIM: To estimate the prevalence and severity of premalignant conditions and lesions in FDRs of EOGC patients.
METHODS: A case-control study was conducted encompassing 103 FDRs of EOGC patients (cases) and 101 age- and gender-matched controls, all submitted to upper GI endoscopy and OLGA and OLGIM used for staging as well as modified versions with exclusion of the biopsies from incisura angularis in the analysis.
RESULTS: Helicobacter pylori infection was present in 82% of cases (P = 0.001). Atrophy was present in 70% of cases (OLGA stages I-IV). High-risk stages (III-IV) were identified only in cases (19%) (P < 0.001). Dysplasia was diagnosed only in cases (n = 7, P = 0.007). The application of OLGIM, modified OLGA and modified OLGIM classifications led to downgrade of stages in comparison with the original OLGA classification (27%, 15% and 30% respectively). In all classification systems, dysplastic lesions clustered (86%) in high-risk stages.
CONCLUSIONS: FDRs of EOGC patients have, even at young ages, a high prevalence of H. pylori infection, high-risk OLGA and OLGIM stages and dysplasia. These patients should undergo accurate endoscopic observation with at least four biopsies in antrum and corpus to allow adequate staging and follow-up of premalignant conditions and lesions scored in high-risk stages, in accordance with international guidelines recently proposed.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22548492     DOI: 10.1111/j.1365-2036.2012.05111.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  19 in total

1.  High Prevalence of Gastric Preneoplastic Lesions in East Asians and Hispanics in the USA.

Authors:  Christie E Choi; Amnon Sonnenberg; Kevin Turner; Robert M Genta
Journal:  Dig Dis Sci       Date:  2015-02-28       Impact factor: 3.199

2.  Operative link on gastritis assessment stage is an appropriate predictor of early gastric cancer.

Authors:  Ying Zhou; Hai-Yan Li; Jing-Jing Zhang; Xiao-Yu Chen; Zhi-Zheng Ge; Xiao-Bo Li
Journal:  World J Gastroenterol       Date:  2016-04-07       Impact factor: 5.742

3.  Helicobacter pylori chronic infection and mucosal inflammation switches the human gastric glycosylation pathways.

Authors:  Ana Magalhães; Ricardo Marcos-Pinto; Alison V Nairn; Mitche Dela Rosa; Rui M Ferreira; Susana Junqueira-Neto; Daniela Freitas; Joana Gomes; Patrícia Oliveira; Marta R Santos; Nuno T Marcos; Wen Xiaogang; Céu Figueiredo; Carla Oliveira; Mário Dinis-Ribeiro; Fátima Carneiro; Kelley W Moremen; Leonor David; Celso A Reis
Journal:  Biochim Biophys Acta       Date:  2015-07-02

Review 4.  Gastric cancer: prevention, screening and early diagnosis.

Authors:  Victor Pasechnikov; Sergej Chukov; Evgeny Fedorov; Ilze Kikuste; Marcis Leja
Journal:  World J Gastroenterol       Date:  2014-10-14       Impact factor: 5.742

5.  Prevalence of Gastric Preneoplastic Lesions in First-Degree Relatives of Patients with Gastric Cancer: a Cross-Sectional Study.

Authors:  Sergio Sotelo; Carlos Manterola; Tamara Otzen; Erik Morales; Iván Castillo
Journal:  J Gastrointest Cancer       Date:  2022-04-30

6.  Intestinal metaplasia surveillance: searching for the road-map.

Authors:  Angelo Zullo; Cesare Hassan; Alessandro Repici; Bruno Annibale
Journal:  World J Gastroenterol       Date:  2013-03-14       Impact factor: 5.742

7.  Gastritis staging: interobserver agreement by applying OLGA and OLGIM systems.

Authors:  Sergejs Isajevs; Inta Liepniece-Karele; Dainius Janciauskas; Georgijs Moisejevs; Viesturs Putnins; Konrads Funka; Ilze Kikuste; Aigars Vanags; Ivars Tolmanis; Marcis Leja
Journal:  Virchows Arch       Date:  2014-01-30       Impact factor: 4.064

Review 8.  Current evidence of effects of Helicobacter pylori eradication on prevention of gastric cancer.

Authors:  Il Ju Choi
Journal:  Korean J Intern Med       Date:  2013-08-14       Impact factor: 2.884

9.  Genomic single nucleotide polymorphisms in the offspring of gastric cancer patients predispose to spasmolytic polypeptide-expressing metaplasia after H. pylori infection.

Authors:  Yu-Ching Tsai; Wei-Hsin Hsiao; Sheng-Hsiang Lin; Hsiao-Bai Yang; Hsiu-Chi Cheng; Wei-Lun Chang; Cheng-Chan Lu; Bor-Shyang Sheu
Journal:  J Biomed Sci       Date:  2015-02-21       Impact factor: 8.410

10.  Dietary Factors and Gastric Intestinal Metaplasia Risk Among US Veterans.

Authors:  Mimi C Tan; Niharika Mallepally; Quynh Ho; Yan Liu; Hashem B El-Serag; Aaron P Thrift
Journal:  Dig Dis Sci       Date:  2020-06-13       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.